CHINA PHARMA HOLDINGS, INC. Proceeds from Issuance of Convertible Preferred Stock
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Proceeds from Issuance of Convertible Preferred Stock of $5.00 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock · last filed 2023-03-30
- CHINA PHARMA HOLDINGS, INC. proceeds from issuance of convertible preferred stock for the quarter ending 2021-12-31 was $7.32M.
- CHINA PHARMA HOLDINGS, INC. proceeds from issuance of convertible preferred stock for the quarter ending 2021-09-30 was -$2.16M.
- CHINA PHARMA HOLDINGS, INC. proceeds from issuance of convertible preferred stock for the quarter ending 2021-06-30 was -$301.00.
- CHINA PHARMA HOLDINGS, INC. proceeds from issuance of convertible preferred stock for the quarter ending 2021-03-31 was -$154.22K.
- CHINA PHARMA HOLDINGS, INC. proceeds from issuance of convertible preferred stock for fiscal 2021 was $5.00M.
| Period end | Proceeds from Issuance of Convertible Preferred Stock 3 month | Proceeds from Issuance of Convertible Preferred Stock 6 month | Proceeds from Issuance of Convertible Preferred Stock 9 month | Proceeds from Issuance of Convertible Preferred Stock 12 month |
|---|---|---|---|---|
| 2021-12-31 | $7.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $5.15M derived: sum of 2 quarters · filed 2023-03-30 | $5.15M derived: sum of 3 quarters · filed 2023-03-30 | $5.00M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$2.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$2.16M derived: sum of 2 quarters · filed 2022-11-14 | -$2.32M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$301.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$154.52K 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | -$154.22K 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |